Drug research
0.5 mL dose of PCV20
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy InfantsNCT06720038 | PCVX | Phase 2 | Active not recruiting | 2027-12Estimated |
Regulatory dates and decisions
| No regulatory events published here yet.Events appear after automated checks of their supporting sources. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |